Transplantation Research Center, Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Transplantation Center, Seoul National University Hospital, Jongno, Korea.
Geriatr Gerontol Int. 2019 May;19(5):392-398. doi: 10.1111/ggi.13630. Epub 2019 Feb 20.
The aim of the present study was to investigate the clinical outcomes of kidney transplantation (KT) in elderly recipients compared with those in young recipients.
We compared the incidence of biopsy-proven acute rejection, death-censored allograft survival and all-cause mortality, and also compared the impact of high sensitization or desensitization on the clinical outcomes of elderly and young recipients.
A total of 4966 KT recipients from the Korean Organ Transplantation Registry were included. The definition of elderly recipients was based on age >60 years (n = 356), and recipients aged <60 years were defined as young recipients (n = 4610). The incidence of biopsy-proven acute rejection did not differ between the two groups irrespective of the donor type; however, the impact of high sensitization was significant only in young recipients. Being an elderly recipient was an independent risk factor for death-censored allograft failure in terms of overall and living donor KT, but not with deceased donor KT. In regard to patient death, being an elderly recipient was a significant predictor in general and in the two subgroups, and desensitization showed a significant interaction with death in the elderly recipients in the living donor KT group.
In conclusion, KT in elderly recipients might be associated with poor allograft or patient survival in general, and especially, desensitization therapy carried out in these patients might increase the risk of patient mortality. Geriatr Gerontol Int 2019; 19: 392-398.
本研究旨在比较老年受者与年轻受者肾移植(KT)的临床结局。
我们比较了活检证实的急性排斥反应、死亡风险校正移植物存活率和全因死亡率的发生率,并比较了高致敏或脱敏对老年和年轻受者临床结局的影响。
共纳入韩国器官移植登记处的 4966 例 KT 受者。老年受者的定义为年龄>60 岁(n=356),年龄<60 岁的受者定义为年轻受者(n=4610)。无论供者类型如何,两组之间活检证实的急性排斥反应发生率均无差异;然而,高致敏的影响仅在年轻受者中显著。对于整体和活体供体 KT,老年受者是死亡风险校正移植物失败的独立危险因素,但对于尸体供体 KT 则不是。就患者死亡而言,老年受者在一般情况下和两个亚组中都是一个显著的预测因素,并且在活体供体 KT 组中,脱敏治疗与老年受者的死亡之间存在显著的相互作用。
总之,老年受者的 KT 可能与移植物或患者的总体存活率较差有关,特别是在这些患者中进行脱敏治疗可能会增加患者死亡的风险。老年医学与老年健康 2019;19:392-398。